Instrumento Inactivo

Otros idiomas Bio-Path Holdings Inc Nasdaq

Acciones

US09057N2018

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules	05/06
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 24	04/06
Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules	04/06
Bio-Path Holdings, Inc. announced that it expects to receive $4.000001 million in funding	04/06
Sector Update: Health Care Stocks Gain Late Afternoon	03/06
Top Midday Gainers	03/06
Wall Street Set to Open Slightly Higher Monday as Investors Await Key Manufacturing Data for May	03/06
Investors Await Key Manufacturing Data as US Futures Nudge Higher in Monday's Premarket Session	03/06
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual Meeting	03/06
Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia At American Society of Clinical Oncology Annual Meeting	03/06
Bio-Path Holdings to Present Data at 2024 European Hematology Association Congress	24/05
Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual Meeting	23/05
Bio-Path: Q1 Earnings Snapshot	15/05
Bio-Path Holdings Reports First Quarter 2024 Financial Results	15/05
Bio-Path Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05
Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024	08/05
Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	22/04
Bio-Path Closes $1.2 Million Share Offering	19/04
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-theMarket Under Nasdaq Rules	19/04
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	18/04

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Bio-Path Holdings Inc Nasdaq

Acciones

US09057N2018

Otros idiomas

Filtros